Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Endovascular Thrombectomy Shows No Benefit Over Standard Of Care In MR RESCUE

This article was originally published in The Gray Sheet

Executive Summary

The National Institutes of Health-sponsored trial appears to dash hopes that CT or MRI can select patients for acute stroke treatment with first-generation thrombus retrieval systems.

You may also be interested in...

Research In Brief

Reducing unnecessary CT imaging scans among children could reduce cancer, a new study finds. FDA panelists’ votes appear to be influenced by where they sit. More research news.

Stryker Debuts Next-Gen Clot Remover For Ischemic Stroke, Boosting Neuro Competition

Firm gains 510(k) clearance for Trevo Pro clot removal device for acute ischemic stroke, which will compete with Covidien’s Solitaire FR revascularization device.

Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market

Stryker will gain access to the acute ischemic stroke market by acquiring privately held Concentric Medical for $135 million under a definitive agreement announced Aug. 31.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts